Participants-Of 448 general practitioners in the IKMN region, 152 were willing to participate and ofthese 52 were randomly selected to take part (11% of all general practitioners in the region).
Measurements and main results-A total of 1637 tumours were identified from the general practitioners, of which 252 (15-4%) were not included in the cancer registry. Of these, only 22 (1-3%) were not included in the registry because they had tumours diagnosed clinically in outpatients and therefore had been omitted from the usual sources of information available to the cancer registry (pathology reports, hospital discharge letters). The missed cases were mostly older patients with digestive tract tumours.
Conclusions-On cost-benefit grounds it was not considered feasible to The study aimed at defining the role of general practitioners as primary sources for the cancer registry. For this purpose all general practitioners in the region of the IKMN (n = 468) were sent a letter inviting them to participate in the study. From the positive responders (n = 152) a random sample of 52 practitioners was chosen to participate. These took care of a population of about 160 000 patients, 13% of the total population in the area. All participating general practitioners were visited, so that the purpose of the study and the study design could be explained in detail. The study consisted of two parts. First a retrospective ("prevalence") registry of all patients diagnosed with cancer from January 1985-September 1987 was set up. The practice administrative assistants searched the files of all the patients for this purpose. Deceased should probably have been included in the registry' because these patients had been referred to hospitals which were situated within the catchment area of the registry and were participating in the registry (table I) . These patients should have been notified to the registry either by means of PALGA or through the LMR. Patients referred to non-participating hospitals or hospitals outside the region could not possibly be known to the registry data base. At a later stage, when the national cancer registry system functions, these cases will be notified through that system. > 75 years of age, compared to 23 6°o in the total study population. The age and sex distribution of the 22 "general practitioner only" cases compared to that of the total number of registered cases is shown in table III. Among the "general practitioner only" cases the tumour was located in the digestive tract in 3200 (7/22). There were four lung tumours, two skin cancers, four breast carcinomas, three brain tumours and in two cases the primary tumour was unknown. It thus seems that the underregistration would cause a particular underrepresentation of older patients with digestive tract tumours. The question then arises as to whether the cost-benefit ratio permits the registry to collaborate with general practitioners in the way we did in this study, or whether another way could be found to ensure registration of the general practitioner only cases. The obvious solution is registration after death by means of death certificates. However, until now the Central Bureau for Statistics-the only institution where causes of death are recorded in the Netherlands-has refused to cooperate with the cancer registry! The total project took 41 25 working days. Extrapolating to all general practitioners in our area, this means that 1-7 full time equivalents would be necessary for the first year (provided that the prevalence registry was wanted and needed). For an incidence registry only (eg, after the first year) only one full time equivalent would be required for our region with 12 million inhabitants. If the same system were to be implemented in all regional registries, this would mean a total of 12 additional full time equivalents, at a cost of Dfl 2-273 per general practitioner registration (compared to a "normal" registration for which Dfl 100 is paid).
The results of this study were discouraging in the sense that it became clear that-at least in the study period-the main source of information for the cancer registry (the pathology laboratories) missed, for some reason or another, 15% of the cases. Part of the problem might be explained by the fact that about one third of the missed cases were basal cell skin carcinomas (table II) . We are aware of the fact that in the first years of the registry some pathologists did not include these tumours in their list of malignancies. In our region haematological neoplasms (leukaemia for example) are not diagnosed in pathology laboratories but rather by the haematologists themselves. Apparently the notification to the registry from this source did not function properly. There is however no clear cut reason why, for example, the urological and/or digestive tract tumours should not have been notified to the registry.
In summary our study showed that our registry was indeed incomplete in the first years after the start. Automatic notification to the registry by pathology laboratories (with the help of PALGA) will hopefully solve this problem for the most part. The main resuilt of our study, however, is that the exclusion of general practitioners as a source of information for the registry would result in an underregistration of only 1.30o. It seems that cost-benefit analysis prohibits the use of a system such as the one employed in our study. To ensure registration of "general practitioner only" cases (and for obvious reasons with regard to follow up) it is mandatory that the registry should have access to death certificates.
The study would not have been possible without the help of the 52 general practitioners in the IKMN area. The registry team was very helpful and without their enthusiasm these data could not have been generated. Frits Bosman made sure that all the data in the computer were turned into understandable tables and Irma van Beuningen time and again typed the manuscript.
